Alexander Zehnder

Alexander Zehnder joined CureVac as Chief Executive Officer in April 2023. He has held roles of increasing complexity and responsibility in the pharmaceutical industry for more than 20 years, across multiple business units and functional areas in Europe, the United States and Japan. Prior to CureVac, he was Global Head of Oncology at Sanofi and held country leadership positions at both headquarter and country level. Dr. Zehnder was also a member of the Oncology leadership team at Roche/Genentech, serving as Vice President, Global Product Strategy and Global Franchise Head Avastin, the company’s blockbuster oncology drug.